jak2 | 20771
JAK2 mutation p.V617F
Keywords:
CML
Chronic myeloid leukemia
Essential thrombocythemia
Leukocytosis
MPN
Myeloproliferation
Myleoproliferative Neoplasm
Polycythemia vera
Polyglobulia
Splenomegaly
essential thrombocytosis
osteomyelofibrosis
polycythemia
Status
| Material |
|
||
|---|---|---|---|
| Hint |
There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. | Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent).
|
||
| Min. volume | 4 mL | ||
| Stability |
Stability
1 day / 18-25°C
|
||
| Duration | 1 week | ||
| Frequency | 1 x per week | ||
| Method | Next Generation Sequencing |
Price/Rate
| Price |
Price
CHF 470.60
|
|---|---|
| Rate |
Rate
470.60 TP
|
Reference values
| Value and unit | Age and unit | Sex |
|---|---|---|
| negative | f+m |
